StockData
Jasper Therapeutics, Inc. logo

Jasper Therapeutics, Inc. (JSPR) stock

JSPRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$10.34−1.43 (-12.15%)

Close on Nov 17, 2026Market cap $344.06MP/E –Yield –

Earnings

Jasper Therapeutics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Nov 9, 2026
Q3 FY2026 · estimated, before the open
Revenue, Q2 FY2026
–
EPS, Q2 FY2026
-$0.10
-$1.74 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Jasper Therapeutics's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q3 FY2026ended Sep 30, 2026Nov 9, 2026Expected––––
Q2 FY2026ended Jun 30, 2026Aug 14, 2026after the close––-$0.10Release
Q1 FY2026ended Mar 31, 2026May 14, 2026after the close––-$0.04Release
Q4 FY2025ended Dec 31, 2025Mar 30, 2026after the close–––Release
Q3 FY2025ended Sep 30, 2025Nov 10, 2025before the open–––Release
Q2 FY2025ended Jun 30, 2025Aug 13, 2025after the close––-$1.74Release
Q1 FY2025ended Mar 31, 2025May 12, 2025after the close––-$1.41Release
Q4 FY2024ended Dec 31, 2024Feb 27, 2025before the open––-$1.62Release
Q3 FY2024ended Sep 30, 2024Nov 7, 2024before the open––-$1.24Release
Q4 FY2023ended Dec 31, 2023Mar 4, 2024before the open––-$1.50Release
Q2 FY2023ended Jun 30, 2023Aug 11, 2023after the close––-$0.15Release
Q1 FY2023ended Mar 31, 2023May 12, 2023after the close––-$0.16Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Jasper Therapeutics has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Jasper Therapeutics puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Jasper Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. News
  3. Update
  4. News
  5. News
  6. Results
  7. Update
  8. Update
  9. Update
  10. Results
  11. Results
  12. News
  13. News
  14. News
  15. News

See a number that looks wrong?